Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTanfield Regulatory News (TAN)

Share Price Information for Tanfield (TAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.00
Bid: 3.70
Ask: 4.10
Change: -0.15 (-3.70%)
Spread: 0.40 (10.811%)
Open: 4.00
High: 4.00
Low: 4.00
Prev. Close: 4.05
TAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

28 Sep 2018 07:00

RNS Number : 2181C
Tanfield Group PLC
28 September 2018
 

Tanfield Group Plc

 

("Tanfield", or "the Company")

 

Interim Results for the six-month period to 30 June 2018

 

 

Tanfield, an investing company as defined by AIM Rules, announces its half year results for the period ending 30 June 2018. The unaudited financial information will shortly be available on the Company website at www.tanfieldgroup.com.

 

Background

 

The Company is currently defined as an investing company that has two passive investments. This status resulted from the disposal of Smith Electric Vehicles in 2010 and the disposal of Snorkel Europe Limited in October 2013. Tanfield currently owns 49% of Snorkel International Holdings LLC ("Snorkel") and 5.76% of Smith Electric Vehicles Corp. ("Smith").

 

The strategy of the Company in relation to these investments is to return as much as possible of any realised value to shareholders as events occur and circumstances allow, subject to compliance with any legal requirements associated with such distributions.

 

Summary

· As reported in the Snorkel Investment Update on 20 September 2018, the Board have impaired the Snorkel investment value to £19.1m ($25.3m), which represents approximately 12p per share.

· Smith continues to be held at a nil balance sheet value following the impairment of the investment at the end of 2015.

· In June 2018, Snorkel indicated to the Board that it expects Xtreme will cause SKL Holdings to exercise its call option at the earliest opportunity, in October 2018. However, this has not been confirmed by Xtreme or SKL Holdings.

· Based on the information currently available to the Board, it is likely that the trailing 12 month EBITDA at October 2018 will result in the price of the call option being at best a modest amount, possibly nil, but this will need to be validated at the time and consequently the Board has restricted its current valuation of the Company's interest in Snorkel to the priority amount and preferred return values only.

· As reported in the Snorkel Investment Update on 20 September 2018, Charles Brooks, the former Chief Financial Officer of Tanfield Group Plc who had significant input in to the key documents pertaining to the joint venture between Tanfield and Xtreme and whose employment transferred following the joint venture and who is now the Chief Financial Officer at both Snorkel and Xtreme, has made assertions that the preferred interest position is only applicable until 30 September 2018, after which date the value will be nil. The Board do not agree with the assertions made by Mr Brooks and are of the belief that the intent of the agreement requires the payment of the preferred interest position prior to or in conjunction with Xtreme seeking to exercise the call option to acquire Tanfield's equity in Snorkel.

· Whilst there is no formal dispute with Xtreme currently, the Board has inferred from its correspondence with Mr Brooks that this may occur in due course. Should Xtreme attempt to exercise its call option and dispute that the adjusted preferred interest position is payable, the Board will vigorously defend its position that the preferred interest is payable.

· The Company's operating loss in H1 2018 reduced to £94k (H1 2017: £109k). The retained loss for the period, after a £17.2m impairment of the Snorkel investment valuation, was £17.3m (H1 2017: £0.1m).

 

 

Overview of investments

 

Based on the unaudited financial information received from Snorkel, during the first six months of 2018 the business achieved further sales growth resulting in sales of $96.3m, an increase of 21% compared to H1 2017 when sales were $79.7m. Should the trend of sales growth continue for the remainder of the year, the Board believes 2018 could see sales in excess of $200m. The reported gross profit for the period was $12.3m, an increase of $1.7m compared to H1 2017 ($10.6m). Despite the $1.7m increase in gross profit, the operating profit, excluding depreciation, saw a $0.7m decrease to $0.8m compared to H1 2017 ($1.5m). This was as a result of a material increase in selling, general and admin costs of $2.4m during the first 6 months of 2018, up to $11.5m in H1 2018 from $9.1m in H1 2017. As a comparison, the value of selling, general and admin costs in H1 2016 was $8.9m which is consistent with the H1 2017 value of $9.1m.

 

As referenced in the summary, whilst there is no formal dispute with Xtreme currently, should Xtreme attempt to exercise its call option and dispute that the adjusted preferred interest position is payable, the Board will vigorously defend its position that the preferred interest is payable.

 

In 2015 the investment in Smith was impaired to nil due to the uncertainty around its future and the level of funding it required. The situation continues to be monitored but the Board is of the opinion that it is highly unlikely that any value will materialise from the investment.

 

 

 

 

 

For further information:

 

Tanfield Group Plc

Daryn Robinson 020 7220 1666

 

WH Ireland Limited - Nominated Advisor

James Joyce / Chris Viggor 020 7220 1666

 

 

 

STATEMENT OF COMPREHENSIVE INCOME

FOR THE SIX MONTHS ENDING 30 JUNE 2018

 

 

 

 

 

 

 

 

 

Six months to

30 Jun 18 (unaudited)

Six months to

30 Jun 17 (unaudited)

Year to

 31 Dec 17

 (audited)

 

 

 

 

£000's

£000's

£000's

 

 

 

 

 

 

 

 

Revenue

 

 

-

-

-

 

Staff costs

 

 

(32)

(44)

(83)

 

Other operating income

 

 

15

16

84

 

Other operating expenses

 

 

(77)

(81)

(149)

 

Loss from operations before impairments

 

 

(94)

(109)

(148)

 

Impairment of Investments

 

 

(17,183)

-

-

 

Loss from operations after impairments

 

 

(17,277)

(109)

(148)

 

Finance expense

 

 

-

-

-

 

Finance income

 

 

-

-

-

 

Net finance expense

 

 

-

-

-

 

 

 

 

 

 

Loss from operations before tax

 

 

(17,277)

(109)

(148)

 

Taxation

 

 

-

-

-

 

Loss & total comprehensive income for the period attributable to equity shareholders

(17,277)

(109)

(148)

 

 

 

 

 

 

 

 

Loss per share from operations

 

 

 

 

 

 

Basic and diluted (p)

 

 

(11.0)

(0.1)

(0.1)

 

 

 

 

 

 

 

 

 

 

BALANCE SHEET

AS AT 30 JUNE 2018

 

 

 

 

 

30 Jun 18

(unaudited)

30 Jun 17

(unaudited)

31 Dec 17

(audited)

 

 

 

 

£000's

£000's

£000's

 

Non current assets

 

 

 

 

 

 

Non current Investments

 

 

19,100

36,283

36,283

 

 

 

 

19,100

36,283

36,283

 

Current assets

 

 

 

 

 

 

Trade and other receivables

 

 

32

65

13

 

Cash and cash equivalents

 

 

255

166

134

 

 

 

 

287

231

147

 

 

 

 

 

 

 

 

Total assets

 

 

19,387

36,514

36,430

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

Trade and other payables

 

 

40

101

56

 

 

 

 

40

101

56

 

 

 

 

 

 

 

 

Total liabilities

 

 

40

101

56

 

 

 

 

 

 

 

 

Equity

 

 

 

 

 

 

Share capital

 

 

7,920

7,816

7,816

 

Share premium

 

 

17,336

17,190

17,190

 

Share option reserve

 

 

331

459

331

 

Special reserve

 

 

66,837

66,837

66,837

 

Merger reserve

 

 

1,534

1,534

1,534

 

Retained earnings

 

 

(74,611)

(57,423)

(57,334)

 

Total equity

 

 

19,347

36,413

36,374

 

 

 

 

 

 

 

 

Total equity and total liabilities

 

 

19,387

36,514

36,430

 

 

 

 

 

 

 

 

 

            

 

STATEMENT OF CHANGES IN EQUITY

 

 

 

 

Share capital

 

Share premium

 

Share option reserve

 

Merger reserve

 

Special reserve

 

Retained earnings

 

Total

 

 

£000's

£000's

£000's

£000's

£000's

£000's

£000's

For the 6 month period ended 30 June 2018

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

At 1 January 2018

 

7,816

17,190

331

1,534

66,837

(57,334)

36,374

Comprehensive income

 

 

 

 

 

 

 

 

Loss for the period

 

-

-

-

-

-

(17,277)

(17,277)

Total comprehensive income for the year

 

-

-

-

-

-

(17,277)

(17,277)

Transactions with owners in their capacity as owners:-

 

 

 

 

 

 

 

 

 

Issuance of new shares

 

104

146

-

-

-

-

250

 

At 30 June 2018

 

7,920

17,336

331

1,534

66,837

(74,611)

19,347

 

 

 

 

 

 

 

 

 

 

For the 6 month period ended 30 June 2017

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

At 1 January 2017

 

7,816

17,190

459

1,534

66,837

(57,314)

36,522

Comprehensive income

 

 

 

 

 

 

 

 

Loss for the period

 

-

-

-

-

-

(109)

(109)

Total comprehensive income for the year

 

-

-

-

-

-

(109)

(109)

At 30 June 2017

 

7,816

17,190

459

1,534

66,837

(57,423)

36,413

 

 

 

 

 

 

 

 

 

 

For the year ended 31 December 2017

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

At 1 January 2017

 

7,816

17,190

459

1,534

66,837

(57,314)

36,522

 

Comprehensive income

 

 

 

 

 

 

 

 

 

Loss for the year

 

-

-

-

-

-

(148)

(148)

 

Total comprehensive income for the year

 

-

-

-

-

-

(148)

(148)

 

Transactions with owners in their capacity as owners:-

 

 

 

 

 

 

 

 

 

Share based payments

 

-

-

(128)

-

-

128

-

 

At 31 December 2017

 

7,816

17,190

331

1,534

66,837

(57,334)

36,374

 

                            

 

 

CASH FLOW STATEMENT

FOR THE SIX MONTHS ENDING 30 JUNE 2018

 

 

 

 

Six months to 30 Jun 18 (unaudited)

Six months to 30 Jun 17 (unaudited)

Year to

 31 Dec 17

 (audited)

 

 

 

£000's

£000's

£000's

 

 

 

 

 

 

 

Loss before interest and taxation

 

(17,277)

(109)

(148)

 

Loss on impairment of investments

 

17,183

-

-

 

Operating cash flows before movements in working capital

 

(94)

(109)

(148)

 

Decrease/(increase) in receivables

 

(20)

5

48

 

Increase/(decrease) in payables

 

(15)

1

(35)

 

Net cash used in operating activities

 

(129)

(103)

(135)

 

 

 

 

 

 

 

Cash flow from financing activities

 

 

 

 

 

Proceeds from issuance of ordinary shares net of costs

 

250

-

-

 

Net cash from financing activities

 

250

-

-

 

Net (decrease)/increase in cash and cash equivalents

 

121

(103)

(135)

 

Cash and cash equivalents at the start of period

 

134

269

269

 

Cash and cash equivalents at the end of the period

 

255

166

134

 

        
 

 

1 Basis of preparation

The Interim Report of the Company for the six months ended 30 June 2018 has been prepared in accordance with AIM Rule 18 and not in accordance with IAS34 "Interim Financial Reporting" therefore is not fully in compliance with IFRS.

 

The half year report does not constitute financial statements as defined in Section 434 of the Companies Act 2006 and does not include all of the information and disclosures required for full annual statements. It should be read in conjunction with the annual report and financial statements for the year ended 31 December 2017 which is available on request from the Company's registered office, Sandgate House, 102 Quayside, Newcastle upon Tyne NE1 3DX or can be downloaded from the corporate website www.tanfieldgroup.com.

 

 

2 Accounting Policies

New and amended standards and interpretations effective from 1 January 2018, which have been considered by the Directors, are IFRS9 financial instruments and IFRS15 revenue from contracts with customers. Given the operational status of the company, the Directors have concluded that these standards and interpretations have no impact on the interim results. Therefore, the accounting policies adopted are consistent with those of the annual financial statements for the year ended 31 December 2017, as described in those financial statements. In particular, the accounts have been prepared on a going concern basis, and as set out on page 16 of those financial statements.

 

 

 

 

3 Loss per share

The calculation of the basic and diluted loss per share is based on the following data:

 

Number of shares

 

Six months

Six months

Year to

 

 

to 30 Jun 18

to 30 Jun 17

31 Dec 17

 

 

000's

000's

000's

 

Weighted average number of ordinary shares for the purposes of basic earnings per share

 

157,727

156,324

156,324

Effect of dilutive potential ordinary shares from share options

 

-

129

-

 

Weighted average number of ordinary shares for the purposes of diluted earnings per share

 

157,727

156,453

156,324

 

 

 

Loss

 

Six months

Six months

Year to

 

 

 

to 30 Jun 18

to 30 Jun 17

31 Dec 17

 

From operations

 

000's

000's

000's

 

Loss for the purposes of basic earnings per share being net profit attributable to owners of the parent

 

(17,277)

(109)

(148)

 

Potential dilutive ordinary shares from share options

 

-

-

-

 

Loss for the purposes of diluted earnings per share

 

(17,277)

(109)

(148)

 

 

 

 

 

 

 

Loss per share from operations

 

 

 

 

 

Basic and diluted (p)

 

(11.0)

(0.1)

(0.1)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

                       

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR SEEFLWFASEEU
Date   Source Headline
25th Apr 20249:14 amRNSReplacement Final Results for year end 31 Dec 2023
25th Apr 20247:00 amRNSFinal Results for the year ended 31 Dec 2023
20th Nov 20231:01 pmRNSSnorkel Investment Update
17th Aug 20237:00 amRNSSnorkel Investment Update
24th Jul 20237:00 amRNSInterim Results for the six-months to 30 June 2023
2nd Jun 20237:00 amRNSResult of AGM
18th May 20237:00 amRNSSnorkel Investment Update
21st Apr 20237:00 amRNSFinal Results and Notice of AGM
22nd Feb 20234:35 pmRNSPrice Monitoring Extension
7th Feb 20237:00 amRNSSnorkel Investment Update
15th Nov 20229:54 amRNSSnorkel Investment Update
18th Oct 20224:40 pmRNSSecond Price Monitoring Extn
18th Oct 20224:35 pmRNSPrice Monitoring Extension
18th Oct 202210:48 amRNSSnorkel Investment & Legal Proceeding Update
14th Oct 20221:17 pmRNSSnorkel Investment & Legal Proceeding Update
9th Sep 20227:00 amRNSInterim Results for the six months to 30 June 2022
24th Aug 20227:00 amRNSSnorkel Investment & Loan Subscription Update
3rd Aug 20228:46 amRNSResult of AGM
19th Jul 20224:36 pmRNSPrice Monitoring Extension
30th Jun 20227:00 amRNSFinal Results and Notice of AGM
26th May 202211:44 amRNSSnorkel Investment Update
24th May 20227:00 amRNSLoan Note Instrument
12th May 20224:40 pmRNSSecond Price Monitoring Extn
12th May 20224:35 pmRNSPrice Monitoring Extension
10th May 20227:00 amRNSSnorkel Investment & Legal Proceedings Update
22nd Apr 20224:35 pmRNSPrice Monitoring Extension
3rd Mar 202212:56 pmRNSLoan Subscription Update
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
18th Feb 20224:35 pmRNSPrice Monitoring Extension
31st Jan 20224:41 pmRNSSecond Price Monitoring Extn
31st Jan 20224:36 pmRNSPrice Monitoring Extension
31st Jan 20227:00 amRNSSnorkel Legal Proceedings Update
28th Jan 20224:41 pmRNSSecond Price Monitoring Extn
28th Jan 20224:36 pmRNSPrice Monitoring Extension
27th Jan 20224:37 pmRNSPrice Monitoring Extension
18th Jan 20224:41 pmRNSSecond Price Monitoring Extn
18th Jan 20224:35 pmRNSPrice Monitoring Extension
4th Jan 20224:41 pmRNSSecond Price Monitoring Extn
4th Jan 20224:36 pmRNSPrice Monitoring Extension
29th Dec 20214:41 pmRNSSecond Price Monitoring Extn
29th Dec 20214:35 pmRNSPrice Monitoring Extension
16th Dec 20214:42 pmRNSSecond Price Monitoring Extn
16th Dec 20214:36 pmRNSPrice Monitoring Extension
9th Dec 20214:41 pmRNSSecond Price Monitoring Extn
9th Dec 20214:36 pmRNSPrice Monitoring Extension
3rd Dec 20214:41 pmRNSSecond Price Monitoring Extn
3rd Dec 20214:36 pmRNSPrice Monitoring Extension
29th Nov 20214:36 pmRNSPrice Monitoring Extension
22nd Nov 20214:35 pmRNSPrice Monitoring Extension
18th Nov 20217:00 amRNSSnorkel Investment Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.